Singapore healthtech firms use data enrichment solutions to turn fragmented healthcare data into more reliable, actionable information for AI, interoperability, and digital health innovation. However, making that data usable across clinical systems while meeting Singapore’s healthcare requirements presents challenges that go beyond basic data integration.
For Singapore healthtech startups and established healthcare technology providers, fragmented data can become a barrier to product adoption. A remote-monitoring platform may collect valuable device readings but struggle to integrate them into clinical workflows. An AI healthcare product may perform well in testing but lack the consistent data needed for deployment.
Singapore’s Ministry of Health has reinforced the importance of data quality, governance and infrastructure in supporting healthcare AI. For technology leaders, the immediate question is whether to improve existing data pipelines, develop new enrichment capabilities, or work with a specialist engineering partner.
Key takeaways
- Prioritize data enrichment where it matters: Focus on fragmented clinical data that limits product functionality, AI readiness, or healthcare interoperability.
- Plan for Singapore healthcare standards: Assess SS 719:2025, SS 720:2025, and applicable privacy requirements before expanding integrations.
- Start with a defined use case: Validate data quality, security, integration feasibility, and measurable business outcomes before investing in broader infrastructure.
- Choose the right delivery model: In-house development suits firms with mature engineering capabilities, while co-development can help address talent gaps and product delivery constraints.
- Kyanon Digital recommends retaining ownership of clinical and product decisions while using specialist engineering support where internal capacity limits execution.
Why is data enrichment the missing link for Singaporean healthtech platforms?
Singapore’s national healthtech agency, Synapxe, provides a useful example through HEALIX, a cloud-based healthcare data platform supporting AI and analytics across public healthcare. Its approach demonstrates the value of bringing governed clinical, socioeconomic and other relevant data together for downstream applications.
However, not every healthtech firm needs a new centralized data platform. Kyanon Digital’s data-engineering approach is to assess existing sources, integration dependencies and data-quality gaps before selecting the architecture. If the core problem is inconsistent terminology or missing metadata, targeted enrichment may be more appropriate than replacing an established system.
When to prioritize data enrichment: Invest when inconsistent data or missing context limits product functionality, AI readiness, or interoperability. If existing data is already standardized and the challenge is connecting systems, data integration alone may be sufficient.
Transform your ideas into reality with our services. Get started today!
Our team will contact you within 24 hours.
How do the new SS 719:2025 and SS 720:2025 standards impact your data strategy?
SS 719:2025 and SS 720:2025 help Singapore healthtech firms design interoperable data structures and remote-monitoring interfaces, but they address different technical requirements.
Synapxe reaffirmed their role in March 2026, highlighting how startups can use these standards when developing and validating solutions through the HealthX Innovation Sandbox.
| Standard | Primary focus | Implementation implication |
SS 719:2025 | Standardized healthcare terminology | Map clinical data to relevant terminology and codesets, including SNOMED CT and LOINC where applicable |
| SS 720:2025 | Remote clinical monitoring data exchange | Design consistent interfaces for transmitting monitoring information |
HL7 FHIR | Healthcare information-exchange specification | Implement appropriate resources and APIs based on integration requirements |
SS 719 is a terminology guideline, while SS 720 uses a FHIR-based approach for remote clinical monitoring. Neither automatically makes a product compliant with every Singapore healthcare requirement.
Healthtech teams must also evaluate applicable obligations under the Personal Data Protection Act (PDPA) and healthcare-sector rules. In August 2026, MOH confirmed that data-security requirements apply to AI tools processing patient data, including those hosted on third-party cloud services.
Before choosing an enrichment vendor, request evidence of its ability to implement the necessary terminology mappings, API specifications, data-access controls and audit mechanisms.
Prioritize terminology standardization when inconsistent coding is the bottleneck. Prioritize remote-monitoring interoperability when device-to-provider integration is the main requirement. Confirm the applicable requirements with healthcare and regulatory stakeholders before procurement.
What does a secure healthtech data enrichment architecture look like?
A secure healthtech data enrichment architecture connects healthcare information through four stages: data collection, privacy protection, enrichment, and controlled access. For Singapore healthtech firms, the priority is ensuring data can support business growth, healthcare partnerships, and AI applications without compromising patient privacy or operational reliability.
A well-designed architecture should address four business priorities:
Secure data ingestion – Connect fragmented healthcare systems
Bring information from electronic health records (EHRs), medical devices, laboratory systems, and healthcare applications into a reliable data environment.
Business value: Reduce fragmented information and make it easier to integrate products with healthcare providers without repeatedly rebuilding data connections.
Data protection – Safeguard patient information
Apply appropriate encryption, access controls, and de-identification measures based on how patient information will be used.
Business value: Reduce privacy and security risks while supporting responsible data sharing, healthcare partnerships, and applicable Singapore regulatory requirements.
Data enrichment – Turn raw data into actionable insights
Standardize clinical terminology, improve data consistency, and connect relevant health information to support more meaningful analysis.
Business value: Improve data usability for AI development, predictive analytics, personalized healthcare, and interoperability with clinical systems.
Controlled data access – Enable secure business applications
Provide authorized healthcare professionals, business teams, and AI applications with access to the information they need, supported by monitoring and audit controls.
Business value: Enable new digital health services and analytics capabilities while maintaining appropriate data governance.
What should healthtech firms evaluate before implementation?
A secure architecture should solve a defined business problem, not introduce unnecessary infrastructure complexity.
| Business priority | What to evaluate before investing |
Product integration | Can the solution connect with existing healthcare systems and future partners? |
| Data security | How will sensitive patient information be protected and access controlled? |
AI readiness | Is the enriched data accurate, consistent, and suitable for the intended AI application? |
| Scalability | Can the platform support more users, healthcare providers, and data sources as the business grows? |
Operational cost | What are the implementation, maintenance, cloud, and ongoing governance requirements? |
Kyanon Digital perspective: Healthtech firms should start with one high-value use case rather than investing in extensive data infrastructure upfront. This helps validate integration readiness, data quality, security requirements, and business value before scaling.
For a practical approach, explore Kyanon Digital’s guide on bridging data and AI consulting with execution, which explains how to connect data readiness, governance, and engineering with measurable business outcomes.
Should you build data infrastructure in-house or co-develop with a tech partner?
Co-development can accelerate healthtech product delivery and reduce internal engineering pressure, but it does not automatically shorten compliance reviews or guarantee faster launches. For Singapore healthtech firms, the right approach depends on available funding, internal expertise, product differentiation, and integration requirements.
Hiring specialized data engineers, cloud architects, and healthcare integration specialists can create significant recruitment and operational costs. Partnering with an experienced technology team may help address these capability gaps while allowing internal teams to focus on clinical validation, product development, and market adoption.
When should you build in-house or work with a partner?
Decision factor | In-house development | Co-development with a tech partner |
Best suited for | Established firms with mature engineering teams | Startups or scaling firms facing specialist skill gaps |
| Time-to-market | Depends on hiring capacity and existing infrastructure | May accelerate delivery through available engineering resources |
Upfront investment | Recruitment, salaries, infrastructure, and training | Defined project fees or dedicated-team costs |
Healthcare compliance | Internal responsibility for security and regulatory controls | Partner supports implementation; regulatory accountability remains with the responsible organization |
IP and product control | Direct ownership of architecture and implementation | Ownership depends on contracts and delivery arrangements |
| Long-term operations | Internal teams manage upgrades, security, and maintenance | Responsibilities can be shared through defined support agreements |
When is a hybrid approach more practical?
For many growing healthtech firms, a hybrid model offers a practical balance between engineering capacity and product ownership. Internal teams can retain control of proprietary algorithms, clinical workflows, and product strategy, while a technology partner develops supporting infrastructure such as data pipelines, healthcare API integrations, and data-quality processes.
This approach is particularly relevant when:
- Product launch is approaching, but infrastructure development is delaying clinical testing or integration.
- Engineering capacity is limited, and hiring additional specialists would divert funding from product development.
- Healthcare interoperability is complex, requiring experience with HL7 FHIR, SS 719:2025, or SS 720:2025.
- Long-term flexibility matters, making clear IP ownership, documentation, and knowledge transfer essential.
What should you validate before choosing a partner?
Before committing to a delivery model, healthtech leaders should clarify three priorities:
- Business readiness: What is the available budget, funding runway, and required launch milestone?
- Internal capabilities: Can existing teams manage cloud security, data engineering, and healthcare interoperability?
- Product requirements: Which clinical workflows, sensitive datasets, and healthcare systems must the solution support?
Also confirm whether the proposed infrastructure requires specific cloud-security certifications, such as MTCS Level 3, and how applicable PDPA and healthcare-sector requirements will be addressed. A partner’s reusable components or certifications do not automatically establish compliance for the deployed solution.
For Singapore healthtech firms seeking to scale data infrastructure without expanding their permanent engineering workforce, Kyanon Digital’s Outcome-Based AI Dedicated Agile Team offers a co-development approach. The model aligns dedicated engineering capacity with the client’s product roadmap and agreed sprint outcomes, allowing internal teams to retain responsibility for clinical validation, product strategy, and business priorities.
Recommended next step:
Compare your internal engineering capacity against the product launch roadmap, then identify one infrastructure component suitable for internal development or co-development. Evaluate the decision against delivery milestones, integration readiness, total ownership costs, and long-term maintainability.
Conclusion
For Singapore healthtech firms, data enrichment solutions should address a clear product or business constraint, whether that involves connecting clinical systems, preparing reliable data for AI, or supporting healthcare interoperability. The most practical approach is to start with one high-value use case, evaluate its integration and regulatory requirements, and validate measurable outcomes before scaling. Firms should also assess whether their internal teams have sufficient engineering capacity or whether co-development would better support their product roadmap.
Planning to strengthen your healthtech data infrastructure? Discuss your product roadmap and data integration requirements with Kyanon Digital to identify the right implementation priorities, engineering capabilities, and delivery approach.
References
- Smart Data, Shared Purpose, Seamless Care — Ministry of Health Singapore, 2026.
- AI in Healthcare — NCS Impact 2026 speech — Ministry of Health Singapore, 2026.
- SS 719:2025 Guidelines on data standards (terminology) — Singapore Standards.
- SS 720:2025 Remote clinical monitoring — Singapore Standards.
- Health Information Act — Ministry of Health Singapore.
- Data Security Requirements Apply to AI Tools That Process Patient Data — Ministry of Health Singapore, 2026.
- Mayo Clinic and Microsoft collaborate to develop a frontier AI model for healthcare — Mayo Clinic, 2026.
- EDGE Grant — Enterprise Singapore, 2026.
- How Do You Bridge Data and AI Consulting with Execution? — Kyanon Digital, 2026.
Create project brief with AI